Log In
BCIQ
Print this Print this
 

RVC20

  Manage Alerts
Collapse Summary General Information
Company Humabs BioMed S.A.
DescriptionAntibody targeting antigenic site I of rabies virus (RABV) glycoprotein
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationRabies
Indication DetailsTreat rabies infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today